CAS 1951431-34-7

1H-Pyrazolo[3,4-d]pyrimidine-1-ethanol, 4-amino-3-[6-(cyclopropyloxy)-2-naphthalenyl]-α,α-dimethyl-

Description:

1H-Pyrazolo[3,4-d]pyrimidine-1-ethanol, 4-amino-3-[6-(cyclopropyloxy)-2-naphthalenyl]-α,α-dimethyl- is a complex organic compound characterized by its unique pyrazolo-pyrimidine core structure, which is fused with a naphthalene moiety. This compound features multiple functional groups, including an alcohol (-OH) and an amino (-NH2) group, contributing to its potential reactivity and biological activity. The presence of the cyclopropyloxy group enhances its lipophilicity, which may influence its pharmacokinetic properties. The α,α-dimethyl substitution suggests steric hindrance, potentially affecting the compound's interaction with biological targets. This compound may exhibit interesting pharmacological properties, making it a candidate for further research in medicinal chemistry. Its specific applications and efficacy would depend on its interaction with biological systems, which could be explored through various assays and studies. As with many synthetic compounds, safety and handling precautions should be observed, particularly in laboratory settings.

Formula: C₂₂H₂₃N₅O₂

Synonyms:

• 1H-Pyrazolo[3,4-d]pyrimidine-1-ethanol, 4-amino-3-[6-(cyclopropyloxy)-2-naphthalenyl]-α,α-dimethyl-

BKIDC-1553

CAS: 1951431-34-7

BKIDC-1553, an orally active antiglycolytic agent and bumped kinase inhibitor-derived compound, has a predicted half-life of approximately 17 hours in humans. It inhibits CYP2C8 and Angiotensin Converting Enzyme, making it suitable for cancer research [1].

Formula: C₂₂H₂₃N₅O₂

Color and Shape: Solid

Molecular weight: 389.45

Ref: TM-T85861